Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Presenter: Raj Makkar

October 28, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

JenaValve

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

JenaValve Following Previous Ross Procedure

Presenter: Daniel Zumerkorn Hassan

June 06, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

Partner Content

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

December 4, 2024

Partner Content

A Forward Outlook on TAVR for Aortic Regurgitation

June 21, 2024

Video

Real World Experience of a Dedicated TAVI for AR with the JenaValve Trilogy Valve

June 18, 2024

Advertisement

Top Structural Heart News of 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

JenaValve

JenaValve Following Previous Ross Procedure

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Top Structural Heart News of 2023

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

A Forward Outlook on TAVR for Aortic Regurgitation

Real World Experience of a Dedicated TAVI for AR with the JenaValve Trilogy Valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content